The Q2 Next-Generation Issue: Coping with COVID-19 is Now Live

The Q2 Next-Generation Issue of Pharma’s Almanac is now available in full online at PharmasAlmanac.com.

Our second quarter edition features leading insights from subject matter experts covering a range of scientific topics, with a focus on the variety of responses across the pharma/biopharma industry to the COVID-19 pandemic. The issue contains contributions from a range of industry providers exploring the responsibilities of stakeholders during the crisis, including both the development and manufacturing of new therapies and vaccines to address COVID-19 and ways to optimize supply chains, execute clinical trials, and provide CDMO services for other drugs during these challenging times.

We also explore cutting-edge drug discovery efforts, including epigenetic regulation for chronic organ disease; immune, computational, and cytoskeletal approaches in oncology; new therapeutic approaches for age-related diseases; and potentially the first novel class of antibiotics in a decade.

In addition to an extensive feature exploring different angles of COVID-19 and the SARS-CoV-2 virus, we also explore the history of therapeutic molecules that have changed the world as part of our year-long celebration of the 25th anniversary of That’s Nice, which continues with explorations of the future of healthcare provided by the sponsor companies for That’s Nice’s Road to 2021 campaign.

Along with enjoying the issue, we encourage you to take advantage of our newly redesigned e-newsletters, which grant you access to all Pharma’s Almanac content, Nice Insight research, and topical news stories. Make sure to register on the site to access all of our past and current content.

Best regards,

The Nice Insight Team

www.PharmasAlmanac.com